Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 9 studies | 34% ± 12% | |
endothelial cell | 8 studies | 23% ± 8% | |
oligodendrocyte precursor cell | 8 studies | 43% ± 24% | |
microglial cell | 5 studies | 22% ± 5% | |
astrocyte | 5 studies | 36% ± 9% | |
GABAergic neuron | 4 studies | 40% ± 11% | |
glutamatergic neuron | 3 studies | 65% ± 17% | |
endothelial cell of lymphatic vessel | 3 studies | 18% ± 2% | |
macrophage | 3 studies | 21% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 7 studies | 38% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 2047.13 | 653 / 653 | 100% | 10.93 | 605 / 605 |
brain | 100% | 1195.64 | 2640 / 2642 | 100% | 11.99 | 705 / 705 |
prostate | 100% | 1840.89 | 245 / 245 | 100% | 12.81 | 501 / 502 |
kidney | 100% | 1147.35 | 89 / 89 | 99% | 9.62 | 894 / 901 |
pancreas | 100% | 973.33 | 328 / 328 | 99% | 7.71 | 176 / 178 |
breast | 100% | 1317.21 | 459 / 459 | 98% | 9.28 | 1094 / 1118 |
adrenal gland | 100% | 1394.34 | 258 / 258 | 94% | 7.74 | 217 / 230 |
liver | 100% | 746.57 | 226 / 226 | 94% | 6.83 | 383 / 406 |
skin | 98% | 1138.70 | 1769 / 1809 | 93% | 8.00 | 440 / 472 |
intestine | 100% | 1081.41 | 966 / 966 | 91% | 4.85 | 477 / 527 |
lung | 100% | 993.29 | 576 / 578 | 90% | 5.16 | 1041 / 1155 |
ovary | 100% | 1470.26 | 180 / 180 | 86% | 3.99 | 371 / 430 |
stomach | 100% | 1073.07 | 359 / 359 | 85% | 4.26 | 243 / 286 |
bladder | 100% | 1152.29 | 21 / 21 | 85% | 4.73 | 427 / 504 |
esophagus | 100% | 1037.41 | 1445 / 1445 | 83% | 3.85 | 151 / 183 |
uterus | 100% | 1358.22 | 170 / 170 | 78% | 4.07 | 360 / 459 |
adipose | 100% | 1126.34 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1164.31 | 1335 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 12.24 | 80 / 80 |
spleen | 100% | 1300.32 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.08 | 1 / 1 |
heart | 97% | 557.60 | 832 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 97% | 4.81 | 28 / 29 |
tonsil | 0% | 0 | 0 / 0 | 93% | 4.47 | 42 / 45 |
muscle | 88% | 331.23 | 704 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 82% | 378.71 | 764 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051604 | Biological process | protein maturation |
GO_0006641 | Biological process | triglyceride metabolic process |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
Gene name | LMF1 |
Protein name | Lipase maturation factor 1 (cDNA FLJ52484) Lipase maturation factor Lipase maturation factor 1 Lipase maturation factor 1 (Transmembrane protein 112) |
Synonyms | hCG_22432 JFP11 HMFN1876 C16orf26 TMEM112 LA16c-360B4.1 |
Description | FUNCTION: Involved in the maturation of specific proteins in the endoplasmic reticulum. Required for maturation and transport of active lipoprotein lipase (LPL) through the secretory pathway. Each LMF1 molecule chaperones 50 or more molecules of LPL. . FUNCTION: Involved in the maturation of specific proteins in the endoplasmic reticulum. . FUNCTION: Involved in the maturation of specific proteins in the endoplasmic reticulum. . FUNCTION: Involved in the maturation of specific proteins in the endoplasmic reticulum. . |
Accessions | H3BQC9 ENST00000562380.5 H3BQT4 H3BN37 H3BVI4 H3BP58 H3BSB7 ENST00000566627.5 Q96S06 ENST00000570014.5 ENST00000543238.5 [Q96S06-2] B4DFZ0 ENST00000545827.6 ENST00000568964.5 ENST00000567595.1 ENST00000262301.16 [Q96S06-1] H3BUN8 F5H802 ENST00000565276.5 ENST00000568897.5 ENST00000562226.5 |